Employees: 02 (2023.0)Legal category: 5785Size: PMECreation date: 1990-07-01 (35 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: ANNECY (74000), Haute-Savoie
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE LA ROCADE : revenue, balance sheet and financial ratios
PHARMACIE DE LA ROCADE is a French company
founded 35 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ANNECY (74000),
this company of category PME
shows in 2025 a net income positive of 153 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE LA ROCADE (SIREN 378872873)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
152 830 €
-3 988 €
70 364 €
157 036 €
93 739 €
94 482 €
92 162 €
94 683 €
102 839 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE DE LA ROCADE generates positive net income of 153 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 103 k€ -> 153 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
152 830 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 239%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 22%. The balance between equity and debt is satisfactory.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
238.848%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
22.122%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE LA ROCADE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
352.382
327.015
226.2
164.03
307.172
174.73
110.89
264.099
238.848
Financial autonomy
19.175
21.156
27.561
32.742
21.329
30.836
40.148
22.361
22.122
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
238.852025
2023
2024
2025
Q1: 13.57
Med: 49.47
Q3: 128.28
Average+14 pts over 3 years
In 2025, the debt ratio of PHARMACIE DE LA ROCADE (238.85) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
22.12%2025
2023
2024
2025
Q1: 33.69%
Med: 53.88%
Q3: 72.26%
Watch-14 pts over 3 years
In 2025, the financial autonomy of PHARMACIE DE LA ROCADE (22.1%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 116.04. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
116.04
Liquidity indicators evolution PHARMACIE DE LA ROCADE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
158.583
151.055
145.966
139.715
137.661
153.188
45.869
127.626
116.04
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
116.042025
2023
2024
2025
Q1: 131.48
Med: 182.6
Q3: 258.72
Watch+12 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE DE LA ROCADE (116.04) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of PHARMACIE DE LA ROCADE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DE LA ROCADE is estimated at
2 427 722 €
(range 1 647 464€ - 3 809 431€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1647k€2427k€3809k€
2 427 722 €Range: 1 647 464€ - 3 809 431€
NAF 5 année 2025
Valuation method used
Net Income Multiple
152 830 €
×
15.9x
=2 427 723 €
Range: 1 647 464€ - 3 809 431€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE LA ROCADE with other companies in the same sector:
Frequently asked questions about PHARMACIE DE LA ROCADE
What is the revenue of PHARMACIE DE LA ROCADE ?
The revenue of PHARMACIE DE LA ROCADE is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DE LA ROCADE profitable?
Yes, PHARMACIE DE LA ROCADE generated a net profit of 153 k€ in 2025.
Where is the headquarters of PHARMACIE DE LA ROCADE ?
The headquarters of PHARMACIE DE LA ROCADE is located in ANNECY (74000), in the department Haute-Savoie.
Where to find the tax return of PHARMACIE DE LA ROCADE ?
The tax return of PHARMACIE DE LA ROCADE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE LA ROCADE operate?
PHARMACIE DE LA ROCADE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart